Compounding of Veterinary Drugs for Equine Practitioners

Scott D Stanley; Krysta Moffitt; Valerie Wiebe

doi:10.1016/j.cveq.2016.12.003

Compounding of Veterinary Drugs for Equine Practitioners

Scott D Stanley, Krysta Moffitt, Valerie Wiebe

Equine Analytical Chemistry Program

Research output: Contribution to journal › Review article

Abstract

Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

Original language	English (US)
Pages (from-to)	213-225
Number of pages	13
Journal	Veterinary Clinics of North America - Equine Practice
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.cveq.2016.12.003
State	Published - Apr 1 2017

Keywords

Compounding
Drugs
Extralabel drug use
Horses

ASJC Scopus subject areas

Equine

Access to Document

10.1016/j.cveq.2016.12.003

Fingerprint Dive into the research topics of 'Compounding of Veterinary Drugs for Equine Practitioners'. Together they form a unique fingerprint.

Cite this

Stanley, S. D., Moffitt, K., & Wiebe, V. (2017). Compounding of Veterinary Drugs for Equine Practitioners. Veterinary Clinics of North America - Equine Practice, 33(1), 213-225. https://doi.org/10.1016/j.cveq.2016.12.003

@article{6ff8403b0bde43518846c6e23b4ec484,

title = "Compounding of Veterinary Drugs for Equine Practitioners",

abstract = "Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.",

keywords = "Compounding, Drugs, Extralabel drug use, Horses",

author = "Stanley, {Scott D} and Krysta Moffitt and Valerie Wiebe",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.cveq.2016.12.003",

language = "English (US)",

volume = "33",

pages = "213--225",

journal = "Veterinary Clinics of North America. Equine Practice",

issn = "0749-0739",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Compounding of Veterinary Drugs for Equine Practitioners

AU - Stanley, Scott D

AU - Moffitt, Krysta

AU - Wiebe, Valerie

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

AB - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.

KW - Compounding

KW - Drugs

KW - Extralabel drug use

KW - Horses

UR - http://www.scopus.com/inward/record.url?scp=85015651067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015651067&partnerID=8YFLogxK

U2 - 10.1016/j.cveq.2016.12.003

DO - 10.1016/j.cveq.2016.12.003

M3 - Review article

C2 - 28325180

AN - SCOPUS:85015651067

VL - 33

SP - 213

EP - 225

JO - Veterinary Clinics of North America. Equine Practice

JF - Veterinary Clinics of North America. Equine Practice

SN - 0749-0739

IS - 1

ER -